Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07521306) titled 'Biomarkers for Predicting Mortality in Patients With Suspected Sepsis' on April 3.

Study Type: Observational

Primary Sponsor: Antalya Training and Research Hospital

Condition: Sepsis Mortality Biomarkers

Recruitment Status: Not recruiting

Date of First Enrollment: May 1, 2023

Target Sample Size: 250

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07521306

Published by HT Digital Content Services with permission from Health Daily Digest....